Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP564687.RAZjAWxznhZWnEmge75RoPJkgYYoe6vJ2B9B4KSxCGHBI130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564687.RAZjAWxznhZWnEmge75RoPJkgYYoe6vJ2B9B4KSxCGHBI130_provenance.
• NP664317.RAXro6wy54mWr74BYKFbhlm9ZC3U8gaNZtNkeR8ETWc9s130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664317.RAXro6wy54mWr74BYKFbhlm9ZC3U8gaNZtNkeR8ETWc9s130_provenance.
• NP419136.RAw4ShDlX-jKnfxobc7YgW_SAc-ePNeV6XMt4vU4GrBKY130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419136.RAw4ShDlX-jKnfxobc7YgW_SAc-ePNeV6XMt4vU4GrBKY130_provenance.
• assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP728533.RA1qwvviVqvr-WhxupoobH8mJ-fljOzvOjD3T6yncKAZw130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728533.RA1qwvviVqvr-WhxupoobH8mJ-fljOzvOjD3T6yncKAZw130_provenance.
• NP645946.RAdcUhF_OhcXbeNQj7UDB0FjH3N9AGURroYcle0MajBL8130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645946.RAdcUhF_OhcXbeNQj7UDB0FjH3N9AGURroYcle0MajBL8130_provenance.
• NP492577.RALn4nciaAfl9IHkuBPgMA0E6yqJMhCDwGAK9A4Zwz76I130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492577.RALn4nciaAfl9IHkuBPgMA0E6yqJMhCDwGAK9A4Zwz76I130_provenance.
• assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP947795.RASKuW5QNcN862YwXkDUZpN8H6SOth0NcMu9I-do9jdsM130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947795.RASKuW5QNcN862YwXkDUZpN8H6SOth0NcMu9I-do9jdsM130_provenance.
• NP645976.RABlLPsvCFXUhoyA4RYHMvRQ7w-1qb-2_9ig9CCEzCN7s130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645976.RABlLPsvCFXUhoyA4RYHMvRQ7w-1qb-2_9ig9CCEzCN7s130_provenance.
• NP336557.RAssGCWCQIOQrqnt1ah1frolxXGcMDzB7J6Wqix4eMTlo130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336557.RAssGCWCQIOQrqnt1ah1frolxXGcMDzB7J6Wqix4eMTlo130_provenance.
• NP336600.RAOZdDUN7hi-J2PME4bDuTSMid5NFe13TsnXHn5lLmfLM130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP336600.RAOZdDUN7hi-J2PME4bDuTSMid5NFe13TsnXHn5lLmfLM130_provenance.
• NP947796.RANHC7KN7X9e40PTgMnk9sFK6znac92hJj-6ldiqCDgXI130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947796.RANHC7KN7X9e40PTgMnk9sFK6znac92hJj-6ldiqCDgXI130_provenance.
• NP947798.RAO40OIWA1FUiXbhMpETlF7Pug97B7mADEjQ5nJBqaJl8130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947798.RAO40OIWA1FUiXbhMpETlF7Pug97B7mADEjQ5nJBqaJl8130_provenance.
• NP947797.RA0JKwTAlPf5-qudN8bN2e82JmuZOiZFyaMwURu5w7Og0130_assertion description "[MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947797.RA0JKwTAlPf5-qudN8bN2e82JmuZOiZFyaMwURu5w7Og0130_provenance.